<!-- .slide: data-background="assets/backdrop.webp" class="dark no-logo" -->

# Modeling personalized interventions in the human gut microbiome

### Christian Diener

<img src="assets/meduni/logo_slogan_dark.png" width="30%">

<br><br>
<div class="footer">
<a href="https://creativecommons.org/licenses/by-sa/4.0/"><i class="bx bx-cctv"></i>CC BY-SA 4.0</a>
<a href="https://dienerlab.com"><i class="bx bxs-home"></i>dienerlab.com</a>
<a href="https://github.com/dienerlab"><i class="bx bxl-github"></i>dienerlab</a>
<a href="https://twitter.com/thaasophobia"><i class="bx bxl-twitter"></i>@thaasophobia</a>
<a href="https://mstdn.science/@thaasophobia"><i class="bx bxl-mastodon"></i>@thaasophobia</a>
</div>

---

## Humans = big bags of bacteria

<div style="display: flex; justify-content: space-evenly; align-items: center">
<img src="assets/allison.webp" width="25%">
<div>

- you provide a home for *~38 trillion bacteria* (versus 30 trillion human cells)
- gut bacteria manufacture about 90 percent of the body's *supply of serotonin*
- *fecal microbial transplant* can ablate some gastro-intestinal diseases
- success of *PD-1 cancer therapy* can be modulated by probiotics

</div></div>

<div class="footnote" style="text-align: right">

illustration by [Allison Kudla](http://allisonx.com/)<br>
Sender et al. 2016, https://doi.org/10.1371/journal.pbio.1002533<br>
Yano et al. 2015, https://doi.org/10.1016/j.cell.2015.02.047<br>
Khoruts et al. 2016, https://doi.org/10.1038/nrgastro.2016.98<br>
Routy et al. 2017, https://doi.org/10.1126/science.aan3706

</div>

---

<!-- .slide: data-background="var(--primary)" class="dark" -->

## Do we know enough of the rules to play the game?

<br><br>

Though we have now sequenced *millions of microbiome samples* from the human gut, mechanisms
and rational design/engineering still eludes us.

Can we explain the resulting *metabolic and biochemical processes* from *genomic* data?

*What quantities* can be readily predicted and validated to do so?

---

## Quantifying Metabolism - Fluxes

<img src="assets/fluxes.png" width="45%">
<video width="45%" autoplay loop>
  <source src="assets/fluxes.mp4" type="video/mp4">
</video>

"How fast does a species grow?" and "How much of this metabolite is produced?" are
questions about *fluxes, not concentrations*.

<div class="footnote">

video courtesy of [S. Nayyak](https://twitter.com/Na_y_ak) and [J. Iwasa](https://twitter.com/janetiwasa)

</div>

---

## Flux Balance Analysis (FBA)

<img src="assets/fba.png" width="100%">

<div class="footnote">

Diener et al. 2020, https://doi.org/10.1128/mSystems.00606-19<br>
Korem, Suez, Zeevi, Weinberger et al. 2015, https://dx.doi.org/10.1126%2Fscience.aac4812
</div>

---

## Screen and validate interventions in the gut microbiome

<img src="assets/approach.webp" width="70%">

---

## Short-chain fatty acids in the human gut

<img src="assets/scfas.png" width="100%">

---

## Rational prediction of SCFA production <i>in vitro</i>

<img src="assets/fig2bc.png" width="80%">

DM38 medium (Venturelli lab), n=882 and 697, respectively

**Nick Bohmann (Gibbons Lab)**, Thomas Gurry (Myota), Ophelia Venturelli (UW-Madison)

---

## ... and <i>ex vivo</i>

<img src="assets/exvivos.png" width="90%">

---

## Strong association with host blood chemistries

<img src="assets/fig5b.png" width="60%">

Arivale cohort (n=3,129), adjusted for sex, age, and BMI

---

## There is no one-fits-all intervention for butyrate production

<img src="assets/fig6.png" width="55%">

---

<!-- .slide: data-background="var(--primary)" class="dark" -->

## Summary

An <i>in silico</i> â†’ <i>ex vivo</i> strategy can be used to rationally predict interventions in the human gut microbiome.

Model-predicted SCFA production is associated with host phenotypes (more than plasma measures).

Likely helpful for large-scale screening but <i>in vivo</i> validation is required.

<div style="display: flex; justify-content: space-evenly; align-items: center; margin-top: 2em">

<img src="assets/nm_july.png" width="15%">

Published at https://doi.org/10.1038/s41564-024-01728-4 .

</div>

---

<!-- .slide: data-background="assets/meduni/campus.png" class="hero no-logo" -->

# Thanks! :smile:

<div style="display: flex; justify-content: space-evenly; align-items: center; color: black; font-size: 80%">

<div style="min-width: 20%">

### ISB

**Sean Gibbons**<br>
Nick Bohmann<br>
Kat Ramos Sarmiento<br>
Nitin Baliga<br>
Noa Rappaport<br>
Tomasz Wilmanski

### Myota

Thomas Gurry

</div><div style="min-width: 20%">


### UW-Madison

Ophelia Venturelli<br>
Erin Ostrem

### Fred Hutch

Lisa Levy<br>
Johanna Lampe

</div></div>

<img src="assets/niddk.svg" width="20%">&nbsp;&nbsp;&nbsp;<img src="assets/coe.jpg" width="20%">


Other research areas we work on:

- microbial niche dynamics and design
- xenobiotic-microbiome interactions (especially statins)
- microbial catabolism of host-derived compounds

---

## Construction of environmental media

<img src="assets/medium.png" width="90%">
